Święcki, P.; Sawicki, R.; Knapp, M.; Kamiński, K.A.; Ptaszyńska-Kopczyńska, K.; Sobkowicz, B.; Lisowska, A.
Galectin-3 as the Prognostic Factor of Adverse Cardiovascular Events in Long-Term Follow up in Patients after Myocardial Infarction—A Pilot Study. J. Clin. Med. 2020, 9, 1640.
https://doi.org/10.3390/jcm9061640
AMA Style
Święcki P, Sawicki R, Knapp M, Kamiński KA, Ptaszyńska-Kopczyńska K, Sobkowicz B, Lisowska A.
Galectin-3 as the Prognostic Factor of Adverse Cardiovascular Events in Long-Term Follow up in Patients after Myocardial Infarction—A Pilot Study. Journal of Clinical Medicine. 2020; 9(6):1640.
https://doi.org/10.3390/jcm9061640
Chicago/Turabian Style
Święcki, Przemysław, Robert Sawicki, Małgorzata Knapp, Karol Adam Kamiński, Katarzyna Ptaszyńska-Kopczyńska, Bożena Sobkowicz, and Anna Lisowska.
2020. "Galectin-3 as the Prognostic Factor of Adverse Cardiovascular Events in Long-Term Follow up in Patients after Myocardial Infarction—A Pilot Study" Journal of Clinical Medicine 9, no. 6: 1640.
https://doi.org/10.3390/jcm9061640
APA Style
Święcki, P., Sawicki, R., Knapp, M., Kamiński, K. A., Ptaszyńska-Kopczyńska, K., Sobkowicz, B., & Lisowska, A.
(2020). Galectin-3 as the Prognostic Factor of Adverse Cardiovascular Events in Long-Term Follow up in Patients after Myocardial Infarction—A Pilot Study. Journal of Clinical Medicine, 9(6), 1640.
https://doi.org/10.3390/jcm9061640
